Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3427359
Max Phase: Preclinical
Molecular Formula: C16H23N3O2
Molecular Weight: 289.38
Molecule Type: Small molecule
Associated Items:
ID: ALA3427359
Max Phase: Preclinical
Molecular Formula: C16H23N3O2
Molecular Weight: 289.38
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Oc1ccc(/C=N/N2CCN(C3CCCC3)CC2)c(O)c1
Standard InChI: InChI=1S/C16H23N3O2/c20-15-6-5-13(16(21)11-15)12-17-19-9-7-18(8-10-19)14-3-1-2-4-14/h5-6,11-12,14,20-21H,1-4,7-10H2/b17-12+
Standard InChI Key: KFDDUIMMXYGZBQ-SFQUDFHCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 289.38 | Molecular Weight (Monoisotopic): 289.1790 | AlogP: 1.99 | #Rotatable Bonds: 3 |
Polar Surface Area: 59.30 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 8.78 | CX Basic pKa: 8.06 | CX LogP: 1.65 | CX LogD: 1.26 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.84 | Np Likeness Score: -0.56 |
1. Mayer N, Schweiger M, Melcher MC, Fledelius C, Zechner R, Zimmermann R, Breinbauer R.. (2015) Structure-activity studies in the development of a hydrazone based inhibitor of adipose-triglyceride lipase (ATGL)., 23 (12): [PMID:25778769] [10.1016/j.bmc.2015.02.051] |
Source(1):